Maxcyte Inc News - MXCT

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

MaxCyte, Inc. Signing of Strategic Platform License

MaxCyte, Inc. 02 April 2024 MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell...

MaxCyte, Inc. Exercise of options and PDMR dealing

MaxCyte, Inc. 02 April 2024 MaxCyte, Inc. ("MaxCyte" or the "Company") Exercise of options and PDMR dealing ROCKVILLE, MD, April 2...

MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR Dealing

MaxCyte, Inc. 20 March 2024 MaxCyte, Inc. ("MaxCyte" or the "Company") Grant of Options, RSUs and PSUs and PDMR Dealing Rockville...

MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR Dealing

MaxCyte, Inc. 20 March 2024 MaxCyte, Inc. ("MaxCyte" or the "Company") Grant of Options, RSUs and PSUs and PDMR Dealing Rockville...

IN BRIEF: MaxCyte loss widens in 2023 as core revenue declines 25%

kville, Maryland-based provider of cell engineering platform technologies developing "next-generation cell therapeutic ...

MaxCyte, Inc. Filing of form 10-K for FY ended December 31, 2023

MaxCyte, Inc. 13 March 2024 MaxCyte announces filing of Form 10-K for the full year period ended December 31, 2023 ROCKVILLE, MD, March...

MaxCyte, Inc. Reports Q4 & FY 2023 Financial Results

MaxCyte, Inc. 13 March 2024 MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance ...

MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance

ROCKVILLE, Md., March 12, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading...

MaxCyte, Inc. TR-1: Notification of major holdings

MaxCyte, Inc. 06 March 2024 TR-1: Notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to...

EARNINGS: dotdigital eyes rosy future; Beeks Financial turns to profit

The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by ...

MaxCyte, Inc. Preliminary FY Results & 2024 Guidance

MaxCyte, Inc. 05 March 2024 MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results ROCKVILLE, MD, March 5...

MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results

ROCKVILLE, Md., March 04, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading...

MaxCyte, Inc. Total Voting Rights

MaxCyte, Inc. 01 March 2024 MaxCyte, Inc. ("MaxCyte" or the "Company") Total Voting Rights ROCKVILLE, Maryland - 1 March...

MaxCyte, Inc. Exercise of options and PDMR dealing

MaxCyte, Inc. 29 February 2024 MaxCyte, Inc. ("MaxCyte" or the "Company") Exercise of options and PDMR dealing ROCKVILLE, MD, February...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Maxcyte Inc (MXCT)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

MXCT News

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

MaxCyte, Inc. Signing of Strategic Platform License

MaxCyte, Inc. Exercise of options and PDMR dealing

MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR Dealing

MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR Dealing

IN BRIEF: MaxCyte loss widens in 2023 as core revenue declines 25%

MaxCyte, Inc. Filing of form 10-K for FY ended December 31, 2023

MaxCyte, Inc. Reports Q4 & FY 2023 Financial Results

MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance

MaxCyte, Inc. TR-1: Notification of major holdings

EARNINGS: dotdigital eyes rosy future; Beeks Financial turns to profit

MaxCyte, Inc. Preliminary FY Results & 2024 Guidance

MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results

MaxCyte, Inc. Total Voting Rights

MaxCyte, Inc. Exercise of options and PDMR dealing

MXCT Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Maxcyte Inc (MXCT) News

Maxcyte Inc (MXCT)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

MXCT News

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

MaxCyte, Inc. Signing of Strategic Platform License

MaxCyte, Inc. Exercise of options and PDMR dealing

MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR Dealing

MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR Dealing

IN BRIEF: MaxCyte loss widens in 2023 as core revenue declines 25%

MaxCyte, Inc. Filing of form 10-K for FY ended December 31, 2023

MaxCyte, Inc. Reports Q4 & FY 2023 Financial Results

MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance

MaxCyte, Inc. TR-1: Notification of major holdings

EARNINGS: dotdigital eyes rosy future; Beeks Financial turns to profit

MaxCyte, Inc. Preliminary FY Results & 2024 Guidance

MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results

MaxCyte, Inc. Total Voting Rights

MaxCyte, Inc. Exercise of options and PDMR dealing

MXCT Discussion

Your Recent History